Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-03 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E S - Sale D 480 -10,000
2025-09-02 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 84.97 -598
2025-09-02 NOTV / Inotiv, Inc. 4 Neff R Matthew S - Sale D 1.6688 -2,000
2025-09-02 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 475.11 -1,197
2025-09-02 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 58.06 598
2025-09-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -1,666
2025-08-31 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 2.39 -8,319
2025-08-29 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 475.90 -36,196
2025-08-27 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 475 -620
2025-08-26 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E M - Exercise D 107.93 10,000
2025-08-26 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W A - Award D 1.85 540,540
2025-08-25 INCY / Incyte Corporation 4 Basi Ramitpal K A - Award D 6,506
2025-08-19 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III S - Sale D 465.04 -1,662
2025-08-18 CRL / Charles River Laboratories International, Inc. 4 LaPlume Joseph W S - Sale D 157.60 -800
2025-08-15 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 86.81 -277
2025-08-15 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 64.25 277
2025-08-13 MXCT / MaxCyte, Inc. 4 Masoud Maher P - Purchase D 1.3722 75,000
2025-08-13 MXCT / MaxCyte, Inc. 4 Brooke William W P - Purchase D 1.29 50,000
2025-08-13 MXCT / MaxCyte, Inc. 4 DOUGLAS RICHARD P - Purchase D 1.388 80,000
2025-08-13 MXCT / MaxCyte, Inc. 4 Swirsky Douglas J P - Purchase D 1.29 50,000
2025-08-13 MXCT / MaxCyte, Inc. 4 Erck Stanley C P - Purchase D 1.3722 100,000
2025-08-07 CRL / Charles River Laboratories International, Inc. 4 LaPlume Joseph W S - Sale D 150.04 -400
2025-08-06 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott P - Purchase D 5.6161 20,000
2025-08-06 NEO / NeoGenomics, Inc. 4 Zook Anthony P. P - Purchase D 5.584 17,900
2025-08-04 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 75.77 -598
2025-08-04 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 58.06 598
2025-08-01 NOTV / Inotiv, Inc. 4 Neff R Matthew S - Sale D 1.9090 -2,000
2025-08-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -14
2025-07-31 NRC / National Research Corporation 4 Freeman Jordan Nicole P - Purchase D 12.97 771
2025-07-28 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E S - Sale D 450.14 -7,500
2025-07-28 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 451.69 -48,487
2025-07-28 MEDP / Medpace Holdings, Inc. 4 EWALD STEPHEN P S - Sale D 450 -3,000
2025-07-28 ABSI / Absci Corporation 4 Busch Andreas P - Purchase D 3.04 50,000
2025-07-28 IQV / IQVIA Holdings Inc. 4 Patel Bhavik F - Taxes D 197.76 -84
2025-07-28 IQV / IQVIA Holdings Inc. 4 Cherofsky Keriann F - Taxes D 197.76 -35
2025-07-24 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J S - Sale D 453.11 -41,801
2025-07-24 MEDP / Medpace Holdings, Inc. 4 Brady Kevin M. S - Sale D 454.23 -12,000
2025-07-24 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J M - Exercise D 107.93 41,801
2025-07-24 MEDP / Medpace Holdings, Inc. 4 Brady Kevin M. M - Exercise D 57.94 12,000
2025-07-23 IQV / IQVIA Holdings Inc. 4 Cherofsky Keriann S - Sale D 191.53 -549
2025-07-23 IQV / IQVIA Holdings Inc. 4 Sherbet Eric S - Sale D 190.05 -5,800
2025-07-23 IQV / IQVIA Holdings Inc. 4 Sherbet Eric M - Exercise D 97.20 11,870
2025-07-23 IQV / IQVIA Holdings Inc. 4 Sherbet Eric D - Sale to Issuer D 190.10 -6,070
2025-07-22 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 54.99 1,972
2025-07-21 INCY / Incyte Corporation 4 Stein Steven H S - Sale D 67.94 -3,706
2025-07-18 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 54.99 4,500
2025-07-16 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 68.36 -785
2025-07-16 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 68.36 -983
2025-07-16 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 68.36 -1,340
2025-07-15 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 69.86 -1,192
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)